Hoosein N M, Gurd R S
FEBS Lett. 1984 Dec 3;178(1):83-6. doi: 10.1016/0014-5793(84)81245-4.
Two human glucagon-like peptides, GLP-1 and GLP-2, which are coencoded with pancreatic glucagon in the preproglucagon gene, do not significantly inhibit [125I]monoiodoglucagon binding to rat liver and brain membranes and do not activate adenylate cyclase in liver plasma membranes. Nevertheless, GLP-1 and GLP-2 were each found to be potent stimulators of both rat hypothalamic and pituitary adenylate cyclase. Only 30-50 pM concentrations of each peptide elicited half-maximal adenylate cyclase stimulation. Our data suggest that GLP-1 and GLP-2 may be neurotransmitters and/or neuroendocrine effectors, which would account for their high degree of sequence conservation through vertebrate evolution.
两种人胰高血糖素样肽,即GLP-1和GLP-2,它们与胰高血糖素原基因中的胰高血糖素共同编码,对[125I]单碘胰高血糖素与大鼠肝和脑膜的结合没有显著抑制作用,也不能激活肝细胞膜中的腺苷酸环化酶。然而,发现GLP-1和GLP-2都是大鼠下丘脑和垂体腺苷酸环化酶的有效刺激剂。每种肽仅30 - 50 pM的浓度就能引起腺苷酸环化酶刺激作用达到半数最大效应。我们的数据表明,GLP-1和GLP-2可能是神经递质和/或神经内分泌效应物,这可以解释它们在脊椎动物进化过程中的高度序列保守性。